Eli Lilly (LLY) FY2017 results: revenue $20.0 billion, up 9.1% on the year
Eli Lilly & Co. (LLY) reported revenue of $20.0 billion for fiscal 2017, the year ended 31 December 2017, up 9.1% on the year before. Net income was -$204 million, and diluted earnings per share $-0.19. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2018.
Revenue
$20.0 billion
+9.1% on the year
FY2010FY2017
Operating margin
n/a
FY2010FY2017
Net income
-$204 million
FY2010FY2017
Diluted EPS
-$0.19
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
19,974
18,313
19,959
+9.1%
Cost of revenue
4,448
4,160
5,037
+6.9%
Gross profit
15,526
14,152
14,922
+9.7%
Gross margin
77.7%
77.3%
74.8%
Research and development
5,096
5,040
4,796
+1.1%
Selling, general and administrative
5,982
5,842
6,533
+2.4%
Interest expense
225
185
161
+21.5%
Pre-tax income
2,305
3,276
2,790
-29.7%
Income tax
2,391
551
382
+333.7%
Effective tax rate
103.7%
16.8%
13.7%
Net income
-204
2,738
2,408
Net margin
-1.0%
14.9%
12.1%
Diluted EPS
-$0.19
$2.58
$2.26
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
5,616
4,851
2,965
+15.8%
Capital expenditure
1,077
1,037
1,066
+3.8%
Free cash flow
4,539
3,814
1,898
+19.0%
Free cash flow margin
22.7%
20.8%
9.5%
Cash from investing
-3,784
-3,139
26.8
Cash from financing
143
-560
-3,111
Depreciation and amortisation
1,567
1,497
1,428
+4.7%
Share-based compensation
281
255
218
+10.2%
Buybacks
300
600
750
-50.0%
Dividends paid
2,192
2,158
2,127
+1.6%
Dividend per share
$2.12
$2.05
n/a
+3.4%
Diluted shares, weighted
1,052m
1,062m
1,066m
-0.9%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
11,592
14,008
14,571
-17.2%
Non-controlling interest
75.7
72.8
19.0
+4.0%
Debt
13,647
10,305
7,978
+32.4%
Other liabilities
19,666
14,420
13,000
+36.4%
Total liabilities and equity
44,981
38,806
35,569
+15.9%
Fixed assets
7,885
8,253
8,054
-4.5%
Goodwill
1,378
3,973
4,040
-65.3%
Intangible assets
1,354
4,358
5,035
-68.9%
Investments
7,164
6,664
4,432
+7.5%
Cash and equivalents
6,212
4,582
3,666
+35.6%
Receivables
3,977
4,029
3,513
-1.3%
Inventory
3,396
3,562
3,446
-4.7%
Other assets
13,614
3,385
3,384
+302.2%
Total assets
44,981
38,806
35,569
+15.9%
10-K for the year ended 31 December 2017, filed 20 February 2018: the filing.